16,284 resources
Start Prev Rows 7400 - 7600 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date |
|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2034 | Bartonella quintana infection (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2039 | Bartonella quintana infection (Tests for Bartonella quintana Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2040 | Bartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2041 | Bartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2042 | Bartonella henselae infection (Tests for Bartonella henselae Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2043 | Bartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2044 | Bartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2045 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2046 | Bartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2047 | Bartonellosis (Tests for Bartonella spp. Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2048 | Bartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2049 | Bartonella spp. (Tests by Microscopic Observation) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2050 | Bartonellosis (Tests for Bartonella spp. by Culture and Identification Method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2051 | Bartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2053 | Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2055 | Cystic Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2057 | Alveolar Echinococcosis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2058 | Echinococcosis (Tests for Echinococcus species Antibody) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2059 | Echinococcus species (Tests by Microscopic Observation) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2063 | Genital Warts (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2065 | Diphyllobothriasis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2067 | Nontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2072 | Pelvic Inflammatory Disease (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2073 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2074 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2076 | Lower Abdominal Tenderness (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2081 | Leukocytosis (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2084 | Pelvic Abscess (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2085 | Leukocytes [Concentration] (Tests in Blood by Any Method) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2088 | Nongonococcal Urethritis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2090 | Urethritis (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2092 | Urethral discharge (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2094 | Dysuria (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2095 | Gonorrhea (Tests for Neisseria gonorrhoeae Antigen) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2100 | Rhinitis (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2102 | Pleuritis (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2103 | Gamma Glutamyl Transferase in Serum (Tests for Gamma Glutamyl Transferase in Serum) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2107 | Methemoglobinemia (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2108 | Methemoglobinemia [Non Congenital] (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2109 | Methemoglobinemia (Tests for Methemoglobin in Blood [Quantitative]) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2111 | Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2113 | Fetal Anencephaly (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2115 | Cleft Lip Alone (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2118 | Cleft Palate Alone (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2120 | Cleft Lip with Cleft Palate (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2123 | Spina Bifida (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2125 | Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2127 | Fetal Down Syndrome (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2128 | Down Syndrome (Tests for Trisomy 21 Chromosomal Anomaly) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2130 | Bacteremia (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2132 | Gastroschisis (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2134 | Fatal Familial Insomnia (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2136 | Gerstmann Straussler Scheinker Syndrome (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2138 | Prion Disease (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2139 | Prion Disease (Tests for Abnormal PRNP Gene Variant) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2141 | Phenylketonuria (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2148 | Limb Reduction (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2149 | NU_Influenza (Test Panels for Novel influenza A virus Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2151 | Congenital Hearing Loss (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2152 | Naegleria fowleri PAM (Test Panels for Naegleria fowleri Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2155 | Congenital Hypothyroidism [Unspecified] (Disorders) (ICD10CM) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2156 | Thyroid_stimulating hormone (TSH) [Quantitative] (Tests in serum or plasma by any method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2157 | Mpox (Combination Tests that include mpox virus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2158 | Orthopox (Combination Tests that include Orthopoxvirus Nucleic Acid) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2159 | Mpox (Test Panels for mpox virus Nucleic Acid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.216 | Pertussis (Tests for Bordetella pertussis Antibody [Excluding Pertussis Toxin Antibody]) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2160 | Orthopox (Test Panels for orthopoxvirus Nucleic Acid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2161 | COVID_19 (Combination Tests that include SARS_CoV_2 Nucleic Acid) | active | 2023-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2166 | Hantavirus Infection (Test Panels for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2167 | Organisms (Tests in Cerebrospinal Fluid by Culture and Identification Method) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2168 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2169 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis in Cerebrospinal Fluid by Culture and Identification) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2170 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2171 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis in Unspecified Specimen by Culture and Identification) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2172 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2173 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2174 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2175 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2176 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2177 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2178 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Antigen in Unspecified Specimen) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2179 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Antigen in Unspecified Specimen) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.218 | Listeriosis (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2180 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Unspecified Specimen by Microscopic Observation) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2181 | Organisms (Tests by Microscopic Observation in Cerebrospinal Fluid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2183 | Bacteria [Causing Encephalitis] (Tests for Bacteria Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2187 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2188 | Fungi [Causing Encephalitis] (Tests for Fungi Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2189 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis in Cerebrospinal Fluid by Microscopic Observation) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2190 | Parasites [Causing Encephalitis] (Tests for Parasites Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2192 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Nucleic Acid in Cerebrospinal Fluid) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2193 | Viruses [Causing Encephalitis] (Tests for Viruses Causing Encephalitis Antigen in Cerebrospinal Fluid) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2198 | Anaplasmosis (Disorders) (ICD10CM) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2199 | NU_Organisms (Tests in Specimen from Wound by Culture and Identification Method | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2200 | Organisms (Tests by Animal Inoculation Method) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2201 | Agricultural Chemical Poisoning [Unspecified Chemical] (Disorders) (ICD10CM) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2203 | Abnormal Lung Sounds (ICD10CM) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2205 | Anemia [Unspecified Cause] (ICD10CM) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2206 | Creatinine (Tests in Serum by Any Method) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2207 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Unspecified Specimen) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2208 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Tests by Microscopic Observation in Blood) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2210 | Histopathology or Cytopathology Tests by Microscopic Observation | active | 2023-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2211 | Ehrlichiosis (Tests for Ehrlichia species IgG Antibody) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2213 | Invasive Cronobacter Infection (Tests for Cronobacter species by Culture and Identification Method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2215 | Necrotizing Enterocolitis (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2217 | Abscess [Brain] (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2219 | Urinary Tract Infection (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2222 | Organisms (Tests in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2223 | Congenital Cytomegalovirus (Tests for CMV Antigen by Immunohistochemical Stain) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2224 | Congenital Cytomegalovirus (Tests for CMV Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2225 | Congenital Cytomegalovirus (Tests for CMV in Amniotic Fluid by Culture and Identification Method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2226 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid in Amniotic Fluid by NAAT) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2227 | Congenital Cytomegalovirus (Tests for CMV Antigen in Whole Blood) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2228 | Congenital Cytomegalovirus (Tests for CMV Antigen) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2229 | Congenital Cytomegalovirus (Tests for CMV by Culture and Identification Method) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2230 | Congenital Cytomegalovirus (Tests for CMV Nucleic Acid by NAAT) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2232 | Congenital Cytomegalovirus Infection (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2234 | Cytomegalovirus Disease (Disorders) (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2235 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen by Immunohistochemical Stain) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2236 | Toxoplasmosis (Tests for Toxoplasma gondii Antigen in Tissue by Immunohistochemical Stain) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2237 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2238 | Toxoplasmosis (Tests for Toxoplasma gondii IgG IgM IgA or IgE Antibody in Blood) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2239 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody) | active | 2024-06 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2240 | Toxoplasmosis (Tests for Toxoplasma gondii IgG or IgM Antibody in Cerebrospinal Fluid) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2242 | Stillbirth (ICD10CM) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2243 | Zika Virus Disease (Tests for Zika virus IgM Antibody in Blood or CSF) | active | 2024-01 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2244 | Candida species (Tests by Culture and Identification Method) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2245 | Organisms (Tests in Extrapulmonary Specimen by Culture and Identification) | active | 2025-02 | ||
| us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1146.2246 | Organisms (Tests for Nucleic Acid in Extrapulmonary Specimen) | active | 2024-01 |
FHIR